Literature DB >> 16760366

A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology.

Catherine Laumonier1, Jérôme Segers, Sophie Laurent, Alain Michel, Frédérique Coppée, Alexandra Belayew, Luce Vander Elst, Robert N Muller.   

Abstract

Phosphatidylserine (PS) exposure on the cell surface is an early marker of apoptosis. To select PS binding peptides as vectors of contrast agents to image apoptosis, a phage library has been exposed to perfused mouse livers. Phages not retained on control livers during the first perfusions were used for selections on apoptotic livers in a second series of perfusions. Four selected phages were further evaluated for binding to PS-coated enzyme-linked immunosorbent assay (ELISA) plates. They presented an apparent affinity constant (Ka app) for PS ranging from 6.08x10(10) M to 1.62x10(11)M. These phages did not bind to phosphatidylcholine, and competition with annexin V confirmed their specific interaction with PS. The phage with the highest affinity-bound PS in ELISA with a Ka app=(1.6+/-0.2)x10(11)M. It carried the TLVSSL peptide that was synthesized. Specific competition with annexin V and with the synthetic peptide was performed and confirms the specificity of the interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760366     DOI: 10.1177/1087057106288220

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  15 in total

1.  In vivo targeting of cell death using a synthetic fluorescent molecular probe.

Authors:  Bryan A Smith; Shuzhang Xiao; William Wolter; James Wheeler; Mark A Suckow; Bradley D Smith
Journal:  Apoptosis       Date:  2011-07       Impact factor: 4.677

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  NMR chemical shift study of the interaction of selected peptides with liposomal and micellar models of apoptotic cells.

Authors:  Aurore Van Koninckxloo; Céline Henoumont; Sophie Laurent; Robert N Muller; Luce Vander Elst
Journal:  J Biol Inorg Chem       Date:  2014-10-07       Impact factor: 3.358

4.  Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1.

Authors:  Jaspal Singh; Satya Prakash Shukla; Tanvi J Desai; D Gomika Udugamasooriya
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

5.  In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe.

Authors:  Bryan A Smith; Seth T Gammon; Shuzhang Xiao; Wei Wang; Sarah Chapman; Ryan McDermott; Mark A Suckow; James R Johnson; David Piwnica-Worms; George W Gokel; Bradley D Smith; W Matthew Leevy
Journal:  Mol Pharm       Date:  2011-03-01       Impact factor: 4.939

Review 6.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

Review 7.  Biomarkers and molecular probes for cell death imaging and targeted therapeutics.

Authors:  Bryan A Smith; Bradley D Smith
Journal:  Bioconjug Chem       Date:  2012-09-26       Impact factor: 4.774

8.  Efficient identification of phosphatidylserine-binding proteins by ORF phage display.

Authors:  Nora B Caberoy; Yixiong Zhou; Gabriela Alvarado; Xianqun Fan; Wei Li
Journal:  Biochem Biophys Res Commun       Date:  2009-06-09       Impact factor: 3.575

Review 9.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

10.  Identification of peptide ligands for targeting to the blood-brain barrier.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Gert Storm; Wim E Hennink; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-02-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.